mevalonic acid and Osteoporosis, Postmenopausal

mevalonic acid has been researched along with Osteoporosis, Postmenopausal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arizono, H; Azuma, Y; Nakamura, K; Ohta, T; Okaniwa, M; Shimizu, T; Taniguchi, T; Uchida, S	1

Other Studies

1 other study(ies) available for mevalonic acid and Osteoporosis, Postmenopausal

Article	Year
[Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2007, Volume: 130, Issue:4 Topics: Alendronate; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Double-Blind Method; Esophagus; Female; Humans; Mevalonic Acid; Osteoclasts; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic	2007

Article

Year

[Pharmacological and clinical profile of once weekly alendronate for the treatment of osteoporosis (Fosamac 35 mg/Bonalon 35 mg)].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2007, Volume: 130, Issue:4

Topics: Alendronate; Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Resorption; Double-Blind Method; Esophagus; Female; Humans; Mevalonic Acid; Osteoclasts; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic

2007